Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Buy
52,406
+3,824
+8% +$823K 0.4% 51
2026
Q1
$10.6M Buy
48,582
+1,496
+3% +$332K 0.37% 49
2025
Q4
$10.8M Sell
47,086
-2,892
-6% -$659K 0.37% 48
2025
Q3
$11.6M Sell
49,978
-1,465
-3% -$298K 0.4% 49
2025
Q2
$9.55M Sell
51,443
-440
-0.8% -$81.8K 0.35% 51
2025
Q1
$10.9M Sell
51,883
-1,179
-2% -$229K 0.44% 46
2024
Q4
$9.43M Buy
53,062
+5,351
+11% +$984K 0.36% 49
2024
Q3
$9.42M Sell
47,711
-276
-0.6% -$51.5K 0.36% 48
2024
Q2
$8.23M Buy
47,987
+4,661
+11% +$772K 0.33% 51
2024
Q1
$7.89M Sell
43,326
-1,580
-4% -$272K 0.32% 51
2023
Q4
$6.96M Buy
44,906
+2,170
+5% +$316K 0.31% 57
2023
Q3
$6.37M Buy
42,736
+386
+0.9% +$56.7K 0.32% 58
2023
Q2
$5.71M Sell
42,350
-1,216
-3% -$178K 0.28% 65
2023
Q1
$6.94M Sell
43,566
-1,405
-3% -$215K 0.36% 50
2022
Q4
$7.27M Sell
44,971
-1,833
-4% -$281K 0.41% 45
2022
Q3
$6.28M Sell
46,804
-341
-0.7% -$48.9K 0.37% 47
2022
Q2
$7.22M Sell
47,145
-11,189
-19% -$1.71M 0.4% 44
2022
Q1
$9.46M Sell
58,334
-9,355
-14% -$1.36M 0.44% 41
2021
Q4
$9.17M Sell
67,689
-609
-0.9% -$71.9K 0.4% 43
2021
Q3
$7.37M Sell
68,298
-2,248
-3% -$257K 0.34% 51
2021
Q2
$7.95M Sell
70,546
-1,113
-2% -$125K 0.37% 49
2021
Q1
$7.75M Sell
71,659
-205
-0.3% -$21.9K 0.39% 48
2020
Q4
$7.7M Buy
71,864
+153
+0.2% +$14.7K 0.42% 47
2020
Q3
$6.28M Sell
71,711
-5,036
-7% -$474K 0.39% 55
2020
Q2
$7.54M Sell
76,747
-1,721
-2% -$152K 0.5% 46
2020
Q1
$5.98M Buy
78,468
+937
+1% +$79.8K 0.48% 47
2019
Q4
$6.86M Buy
77,531
+1,913
+3% +$159K 0.43% 48
2019
Q3
$5.73M Buy
75,618
+2,462
+3% +$169K 0.39% 52
2019
Q2
$5.32M Sell
73,156
-55
-0.1% -$4.32K 0.36% 55
2019
Q1
$5.9M Buy
73,211
+6,557
+10% +$536K 0.41% 52
2018
Q4
$6.14M Buy
66,654
+12,135
+22% +$1.07M 0.49% 48
2018
Q3
$5.16M Buy
54,519
+14,869
+38% +$1.41M 0.34% 59
2018
Q2
$3.67M Sell
39,650
-7,615
-16% -$744K 0.25% 75
2018
Q1
$4.47M Sell
47,265
-10,828
-19% -$1.19M 0.31% 57
2017
Q4
$5.62M Sell
58,093
-16,283
-22% -$1.53M 0.4% 44
2017
Q3
$6.61M Sell
74,376
-8,108
-10% -$617K 0.49% 39
2017
Q2
$5.98M Sell
82,484
-1,519
-2% -$102K 0.47% 44
2017
Q1
$5.47M Sell
84,003
-1,276
-1% -$80.2K 0.45% 51
2016
Q4
$5.34M Sell
85,279
-1,007
-1% -$61.5K 0.47% 46
2016
Q3
$5.44M Buy
86,286
+10,383
+14% +$672K 0.51% 40
2016
Q2
$4.7M Buy
75,903
+3,072
+4% +$187K 0.46% 45
2016
Q1
$4.16M Buy
72,831
+55,863
+329% +$3.11M 0.42% 45
2015
Q4
$1M Sell
16,968
-1,801
-10% -$104K 0.1% 154
2015
Q3
$1.02M Sell
18,769
-8,306
-31% -$541K 0.12% 141
2015
Q2
$1.82M Sell
27,075
-482
-2% -$31.5K 0.19% 104
2015
Q1
$1.61M Sell
27,557
-8,938
-24% -$540K 0.17% 113
2014
Q4
$2.39M Sell
36,495
-762
-2% -$48K 0.26% 81
2014
Q3
$2.15M Sell
37,257
-23,147
-38% -$1.29M 0.24% 81
2014
Q2
$3.41M Sell
60,404
-1,172
-2% -$61.5K 0.38% 54
2014
Q1
$3.17M Sell
61,576
-27,274
-31% -$1.38M 0.36% 58
2013
Q4
$4.69M Sell
88,850
-22,900
-20% -$1.13M 0.55% 37
2013
Q3
$5M Sell
111,750
-752
-0.7% -$33.3K 0.59% 36
2013
Q2
$4.65M Buy
+112,502
New +$4.92M 0.58% 33

Other funds holding ABBV

Fulton Bank's ABBV Position: Q2 2026 in Review

Fulton Bank increased its AbbVie (ABBV) stake by 7.9% in Q2 2026, buying an estimated $823K and bringing the position to 52,406 shares worth $13.2M. The position accounts for 0.4% of the portfolio, ranked #51.

Fulton Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 871 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fulton Bank held 52,406 shares of AbbVie worth $13.2M as of Q2 2026.
  • Fulton Bank bought 3,824 AbbVie shares in Q2 2026, an estimated $823K.
  • AbbVie made up 0.4% of Fulton Bank's portfolio in Q2 2026, its #51 holding.
  • Fulton Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 871 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.